Search

everythinglearnresearchcommunity

for

Search:↓

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Laser hair removal before genital surgery can prevent complications and improve patient satisfaction.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Women have smaller foreheads and different hairline shapes than men.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.